Reforming private drug coverage in Canada: Inefficient drug benefit design and the barriers to change in unionized settings

Highlights • We conducted 18 interviews with companies, unions, insurers and plan advisors. • Interviewees were asked about the benefit design process in unionized settings. • All participants agreed that most private plans failed at providing value for dollar. • Participants blamed lack of information sharing, education, and insurer incentives. • All participants favored some form of government intervention.